Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil | Journal of Clinical Oncology | 2009 | 1.2K |
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies | Oncologist | 2009 | 591 |
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma | Journal of Clinical Oncology | 2009 | 538 |
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer | Journal of Clinical Oncology | 2009 | 533 |
Dose escalation methods in phase I cancer clinical trials | Journal of the National Cancer Institute | 2009 | 528 |
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma | Leukemia | 2009 | 356 |
Phase I study of individualized stereotactic body radiotherapy of liver metastases | Journal of Clinical Oncology | 2009 | 352 |
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer | Journal of Thoracic Oncology | 2009 | 350 |
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study | Nature Genetics | 2009 | 325 |
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas | International Journal of Radiation Oncology Biology Physics | 2009 | 320 |
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma | Leukemia | 2009 | 307 |
Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design | Clinical Breast Cancer | 2009 | 303 |
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial | Leukemia | 2009 | 281 |
Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI | Journal of Magnetic Resonance Imaging | 2009 | 278 |
The EGFRvIII variant in glioblastoma multiforme | Journal of Clinical Neuroscience | 2009 | 276 |
Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma | Journal of Clinical Oncology | 2009 | 255 |
Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies | Cancer | 2009 | 253 |
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline | British Journal of Haematology | 2009 | 252 |
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia | Blood | 2009 | 238 |
The tumor microenvironment and metastatic disease | Clinical and Experimental Metastasis | 2009 | 232 |
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? | Annals of Oncology | 2009 | 222 |
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues | Laboratory Investigation | 2009 | 205 |
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 198 |
Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases | International Journal of Radiation Oncology Biology Physics | 2009 | 197 |
The management of thymoma: a systematic review and practice guideline | Journal of Thoracic Oncology | 2009 | 193 |